Press Releases Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Delayed Hong Kong S.E. Other stock markets 04:47:17 16/05/2024 BST			5-day change	1st Jan Change
0.47 ^HKD	+5.62%		+14.29%	-22.58%

04-12	Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	CI
04-08	Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort	04-08	PR
Clover Announces Positive Phase ? Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)	12-29	AQ
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate	12-12	PR
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	12/09/23	GL
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	12/09/23	AQ
Clover Provides Updates on Business and R&D Pipeline Development	11/07/23	GL
Clover Provides Updates on Business and R&D Pipeline Development	11/07/23	AQ
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China	24/05/23	GL
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China	24/05/23	AQ
Clover Biopharmaceuticals Announces Corporate Updates and Full Year 2022 Financial Results	29/03/23	AQ
Clover Announces Corporate Updates and Full Year 2022 Financial Results	29/03/23	GL
Clover Announces Corporate Updates and Full Year 2022 Financial Results	29/03/23	AQ
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China	19/02/23	GL
Clover Biopharmaceuticals Launches COVID-19 Booster Vaccine in the People's Republic of China	15/02/23	AQ
UPDATE -- Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China	14/02/23	GL
UPDATE -- Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China	14/02/23	GL
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China	14/02/23	AQ
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023	16/01/23	GL
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023	16/01/23	AQ
Clover's Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases	01/12/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Press Releases

Filters